ClinicalTrials.govrestricted
Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?
ClinicalTrials.gov study NCT04477876. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ShareScore
20/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 8
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 4